Loading...
Loading...
Galderma Group AG/ADR
Galderma Group AG/ADR. Spoken Alpha tracks GALDY's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks GALDY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GALDY.
curl https://api.spokenalpha.com/v1/companies/GALDY| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.66 | $0.79 | -16.6% | +1.5% | +2.0% |
| Q4 FY2026 | $0.73 | $0.98 | -26.0% | +7.7% | +7.1% |
| Q3 FY2026 | $0.64 | $0.79 | -18.4% | +1.5% | +1.1% |
| Q2 FY2026 | $0.77 | $1.02 | -24.8% | +2.6% | +2.7% |
| Q1 FY2025 | $0.70 | $0.86 | -18.3% | +7.1% | +6.4% |
| Q4 FY2025 | $0.56 | $0.79 | -28.6% | +5.6% | +7.3% |
| Q3 FY2025 | $0.81 | $0.99 | -18.1% | +5.9% | +5.1% |
| Q2 FY2025 | $0.68 | $0.84 | -18.8% | -1.1% | -2.9% |
| Q1 FY2024 | $0.67 | $0.86 | -22.2% | +1.1% | 0.0% |
| Q4 FY2024 | $0.83 | $1.01 | -18.1% | +7.2% | +9.6% |